Tanhaji, Maina H.

HRN: 22-81-27  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/30/2023
AMPICILLIN 1GM (VIAL)
03/30/2023
03/31/2023
IV
2g
Q6h
Leukocytosis
Waiting Final Action 
03/31/2023
CEFUROXIME 500MG (TAB)
03/31/2023
04/07/2023
PO
500mg
BID X 7 Days
Second Degree RMLE With Repair
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: